+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Missouri Medical Cannabis Market Size, Share & Trends Analysis Report by Product (Flower, Oils & Tinctures), by Application (Chronic Pain, Tourette's), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 80 Pages
  • June 2022
  • Region: United States
  • Grand View Research
  • ID: 5626290
The Missouri medical cannabis market size is expected to reach USD 2.02 billion by 2030. It is expected to expand at a CAGR of 22.7% from 2022 to 2030. Growing evidence of marijuana's health advantages, rising patient knowledge regarding these benefits, and an increase in the prevalence of chronic conditions are the major factors contributing to the market growth. In addition, since November 2018, Missouri has allowed the cultivation, processing, manufacturing, and distribution of medical cannabis. Since then, a sharp rise has been witnessed in the sales of medical cannabis, thereby impelling the growth in the state.



Based on application, the chronic pain segment dominated the market in 2021 with a share of over 25.0% owing to a large patient pool. Pains associated with neurogenic issues, arthritis, low back issues, cancer, headache, neck-related issues, and face-related issues are just a few of the several types of chronic pain. Medical marijuana has been said to help people who are suffering from pain. The market is likely to witness growth during the forecast period as a growing number of people are understanding the importance and benefits of the intake of cannabis-based products.

Based on product, the oils and tinctures segment accounted for the largest revenue share in 2021. Some of the major factors responsible for the segment growth are benefits provided by the utilization of oils and tinctures over smoking flowers and ease of use. In addition, this segment is anticipated to grow at the fastest rate during the forecast period owing to its increasing demand from patients undergoing treatment for health conditions such as PTSD, epilepsy, autism, and chronic pain.

In practically every business, the COVID-19 pandemic has resulted in massive lockdowns, disrupting daily operations and affecting consumer behavior. Retail stores have been closed as the backlash to COVID-19 grows. Due to the suspension of the logistics industry in major raw material-producing countries such as China and India, the market began to experience a supply deficit. Furthermore, supply chain interruptions across the U.S. has led to a tremendous strain on the supply of additional raw materials, thereby constraining the market growth. In addition, this has impacted the manufacturing of cannabis products, and hence the supply chain for medical cannabis in the state has been disrupted.

Missouri Medical Cannabis Market Report Highlights

  • The legalization of marijuana for medical purposes and the increasing number of people who qualify are likely to bolster the market growth in Missouri.
  • Due to factors such as the rising demand for cannabis extracts, the legalization of marijuana for the treatment of various chronic diseases, and new cannabis extract product launches, the oil and tinctures product segment dominated the market in 2021 with a revenue share of over 50.0%.
  • By application, chronic pain led the market with a revenue share of over 25.0% in 2021. This is due to a growth in the use of medicinal cannabis as an efficient therapy for acute pain owing to its ability to dull the perceptions and anti-inflammatory qualities.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Missouri Medical Cannabis Market

What is the estimated value of the Missouri Medical Cannabis Market?

The Missouri Medical Cannabis Market was estimated to be valued at $394.1 Million in 2022.

What is the growth rate of the Missouri Medical Cannabis Market?

The growth rate of the Missouri Medical Cannabis Market is 22.7%, with an estimated value of $2020 Million by 2030.

What is the forecasted size of the Missouri Medical Cannabis Market?

The Missouri Medical Cannabis Market is estimated to be worth $2020 Million by 2030.

Who are the key companies in the Missouri Medical Cannabis Market?

Key companies in the Missouri Medical Cannabis Market include BeLeaf Medical, Blue Sage Cannabis Co., Show Me Alternatives, Heya Wellness, Missouri Wild Alchemy, Organic Remedies, Holistic Industries, Kansas City Cannabis and MOcann Extracts.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Missouri Medical Cannabis Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Missouri Medical Cannabis Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & Growth Prospects Mapping
3.4 Missouri Medical Cannabis Market Analysis Tools
3.4.1 Missouri Medical Cannabis Market-PESTLE Analysis
3.4.1.1 Political & Legal Landscape
3.4.1.2 Environmental Landscape
3.4.1.3 Social Landscape
3.4.1.4 Technology Landscape
3.4.2 Industry Analysis-Porter’s
3.4.2.1 Supplier Power: Moderate
3.4.2.2 Buyer Power: Low
3.4.2.3 Substitution Threat: Low
3.4.2.4 Threat from New Entrants: Moderate
3.4.2.5 Competitive Rivalry: Moderately High
3.4.3 Regulatory Scenario
3.4.4 Opportunity Analysis
3.4.4 Impact of COVID-19 on the market
Chapter 4 Missouri Medical Cannabis Market: Product Estimates & Trend Analysis
4.1 Missouri Medical Cannabis Market: Product Movement Analysis
4.2 Flower
4.2.1 Flower Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3 Oils and Tinctures
4.3.1 Oils & Tinctures Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5 Missouri Medical Cannabis Market: Application Estimates & Trend Analysis
5.1 Missouri Medical Cannabis Market: Application Movement Analysis
5.2 Cancer
5.2.1 Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3 Chronic Pain
5.3.1 Chronic Pain Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4 Depression & Anxiety
5.4.1 Depression & Anxiety Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5 Arthritis
5.5.1 Arthritis Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6 Diabetes
5.6.1 Diabetes Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7 Glaucoma
5.7.1 Glaucoma Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8 Migraines
5.8.1 Migraines Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9 Epilepsy
5.9.1 Epilepsy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10 Multiple Sclerosis
5.10.1 Multiple Sclerosis Market Estimates and Forecasts, 2018-2030 (USD Million)
5.11 AIDS
5.11.1 AIDS Market Estimates and Forecasts, 2018-2030 (USD Million)
5.12 Amyotrophic Lateral Sclerosis
5.12.1 Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018-2030 (USD Million)
5.13 Alzheimer’s Disease
5.13.1 Alzheimer’s Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
5.14 Post-Traumatic Stress Disorder
5.14.1 Post-Traumatic Stress Disorder Market Estimates and Forecasts, 2018-2030 (USD Million)
5.15 Parkinson’s Disease
5.15.1 Parkinson’s Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
5.16 Tourette’s Syndrome
5.16.1 Tourette’s Syndrome Market Estimates and Forecasts, 2018-2030 (USD Million)
5.17 Others
5.17.1 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 BeLeaf Medical
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Strategic initiatives
6.1.2 . Blue Sage Cannabis Co.
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Strategic Initiatives
6.1.3 Show Me Alternatives
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Strategic Initiatives
6.1.4 Heya Wellness
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Strategic Initiatives
6.1.5 Missouri Wild Alchemy
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Strategic Initiatives
6.1.6 Organic Remedies
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Strategic Initiatives
6.1.7 Holistic Industries
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Strategic Initiatives
6.1.8 Kansas City Cannabis
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Strategic Initiatives
6.1.9 LOCAL CANNABIS COMPANY
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Strategic Initiatives
6.1.10 MOcann Extracts
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Strategic Initiatives
List of Tables
Table. 1 Missouri medical cannabis market, by product, 2018-2030 (USD Million)
Table. 2 Missouri medical cannabis market, by application, 2018-2030 (USD Million)
List of Figures
Fig. 1 Missouri medical cannabis market snapshot, 2021 (USD Million)
Fig. 2 Missouri medical cannabis market segmentation
Fig. 3 Missouri medical cannabis market dynamics
Fig. 4 Missouri medical cannabis market driver impact
Fig. 5 Missouri medical cannabis market restraints impact
Fig. 6 Penetration & growth prospects mapping for medical cannabis
Fig. 7 Missouri medical cannabis market: Opportunity analysis
Fig. 8 Missouri medical cannabis market, Product outlook: Key takeaways
Fig. 9 Missouri medical cannabis market: Product movement analysis (2021 & 2030) (USD Million)
Fig. 10 Flower market estimates and forecasts, 2018-2030 (USD Million)
Fig. 11 Oils & Tinctures market estimates and forecasts, 2018-2030 (USD Million)
Fig. 12 Missouri medical cannabis market, application outlook: Key takeaways
Fig. 13 Missouri medical cannabis market: application movement analysis (2021 & 2030)
Fig. 14 Cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 15 Chronic pain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 16 Depression & Anxiety market estimates and forecasts, 2018-2030 (USD Million)
Fig. 17 Arthritis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 18 Diabetes market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Glaucoma market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Migraines market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Epilepsy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Multiple Sclerosis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 AIDS market estimates and forecasts, 2018-2030 (USD Million)
Fig. 24 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Alzheimer’s Disease market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Post-Traumatic Stress Disorder market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Parkinson’s Disease market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Tourette’s Syndrome market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • BeLeaf Medical
  • Blue Sage Cannabis Co.
  • Show Me Alternatives
  • Heya Wellness
  • Missouri Wild Alchemy
  • Organic Remedies
  • Holistic Industries
  • Kansas City Cannabis
  • LOCAL CANNABIS COMPANY
  • MOcann Extracts

Methodology

Loading
LOADING...